Aurobindo arm inks licence pact with Singapore’s Hilleman for paediatric pentavalent vaccine candidate

Aurobindo Pharma’s subsidiary, Auro Vaccines Pvt Ltd said it has signed a license agreement with Hilleman Laboratories Singapore to develop and commercialize a paediatric pentavalent vaccine candidate. The Hyderabad-based pharma company also pointed out that the inking of the licence agreement will not have significant impact on Aurobindo Pharma, its subsidiaries or financials.